Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rubeshan Perumal

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|May 8, 2023
Long COVID: a review and proposed visualization of the complexity of long COVIDRubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
The Lancet. Infectious Diseases|March 25, 2024
The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis-lessons from the South African experienceKogieleum Naidoo, Rubeshan Perumal, Helen Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2022
Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy-Accessing Participants: Incidence, Clinical Course, and OutcomesKogieleum Naidoo, Mikaila C Moodley, Razia Hassan-Moosa, et al.
The Lancet. Microbe|January 12, 2024
Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysisCamus Nimmo, Neda Bionghi, Matthew J Cummings, et al.
The European Respiratory Journal|November 9, 2023
Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysisRubeshan Perumal, Neda Bionghi, Camus Nimmo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 2025
Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and RifampicinEmmanuella Chinonso Osuala, Ivan Nicholas Nkuhairwe, Marothi Peter Letsoalo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 10, 2026
Treatment Outcomes and Drug-Related Adverse Events Across Four Short-Course RR-TB Regimens in South Africa: A Retrospective AnalysisNorbert Ndjeka, Rubeshan Perumal, Kamila Romanowski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2024
Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infectionKarl Reis, Allison Wolf, Rubeshan Perumal, et al.
BMC Infectious Diseases|May 1, 2026
Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysisKevin J Guzman, Allison Wolf, Rubeshan Perumal, et al.
The Lancet. Global Health|August 12, 2022
Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort studyMurray Dryden, Caroline Mudara, Caroline Vika, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|May 8, 2023
Long COVID: a review and proposed visualization of the complexity of long COVIDRubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
The Lancet. Infectious Diseases|March 25, 2024
The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis-lessons from the South African experienceKogieleum Naidoo, Rubeshan Perumal, Helen Cox, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2022
Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy-Accessing Participants: Incidence, Clinical Course, and OutcomesKogieleum Naidoo, Mikaila C Moodley, Razia Hassan-Moosa, et al.
The Lancet. Microbe|January 12, 2024
Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysisCamus Nimmo, Neda Bionghi, Matthew J Cummings, et al.
The European Respiratory Journal|November 9, 2023
Baseline and treatment-emergent bedaquiline resistance in drug-resistant tuberculosis: a systematic review and meta-analysisRubeshan Perumal, Neda Bionghi, Camus Nimmo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 2025
Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and RifampicinEmmanuella Chinonso Osuala, Ivan Nicholas Nkuhairwe, Marothi Peter Letsoalo, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 10, 2026
Treatment Outcomes and Drug-Related Adverse Events Across Four Short-Course RR-TB Regimens in South Africa: A Retrospective AnalysisNorbert Ndjeka, Rubeshan Perumal, Kamila Romanowski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2024
Differentiated service delivery framework for people with multidrug-resistant tuberculosis and HIV co-infectionKarl Reis, Allison Wolf, Rubeshan Perumal, et al.
BMC Infectious Diseases|May 1, 2026
Socio-ecological vulnerability subgroups predict adherence and treatment outcomes in multidrug-resistant tuberculosis and HIV: a latent class analysisKevin J Guzman, Allison Wolf, Rubeshan Perumal, et al.
The Lancet. Global Health|August 12, 2022
Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort studyMurray Dryden, Caroline Mudara, Caroline Vika, et al.
Pageof 6